Format

Send to

Choose Destination
Am J Med. 2018 Jun;131(6):702.e1-702.e5. doi: 10.1016/j.amjmed.2018.01.020. Epub 2018 Feb 3.

Cervical Cancer Screening: What's New? Updates for the Busy Clinician.

Author information

1
Case Western Reserve University School of Medicine, Cleveland, Ohio.
2
Case Western Reserve University School of Medicine, Cleveland, Ohio; Department of Medicine, Case Western Reserve University School of Medicine, Cleveland, Ohio; Louis Stokes Cleveland Veterans Affairs Medical Center, Ohio.
3
Case Western Reserve University School of Medicine, Cleveland, Ohio; Department of Medicine and Primary Care Women's Health, Cleveland Clinic, Ohio. Electronic address: baturp@ccf.org.

Abstract

In the United States, 12,000 women are diagnosed with cervical cancer each year, even though the screening for this disease is safe and effective. There are 3 types of screening options available: cervical cytology (Papanicolaou or "Pap" test), Pap/HPV (human papillomavirus) co-test, and HPV-only test. With simplified options such as HPV-only screening, providers who have been reluctant to incorporate cervical cancer screening into their primary care practice may feel more comfortable with offering these services to women. In this article we review the different cervical cancer screening options that are now available and summarize the various changes in guidelines over the last decade.

KEYWORDS:

Cervical cancer screening; Human papillomavirus–only screening

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center